Your browser doesn't support javascript.
loading
Keratinocytic Vascular Endothelial Growth Factor as a Novel Biomarker for Pathological Skin Condition
Biomolecules & Therapeutics ; : 12-18, 2015.
Article in English | WPRIM | ID: wpr-20366
ABSTRACT
Skin is an emerging target tissue in pharmaceutical and cosmetic science. Safety assessment for dermal toxicity is a critical step for development of topically applicable pharmaceutical agents and ingredients in cosmetics. Urgent needs exist to set up toxicity testing methods for dermal safety, and identification of novel biomarkers for pathological cutaneous alteration is highly required. Here we will discuss if vascular endothelial growth factor (VEGF) has a potential as a biomarker for dermal impairment. Experimental and clinical evidences for induction of keratinocytic VEGF under pathological conditions will be reviewed.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Skin / Biomarkers / Toxicity Tests / Vascular Endothelial Growth Factor A Type of study: Prognostic study Language: English Journal: Biomolecules & Therapeutics Year: 2015 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Skin / Biomarkers / Toxicity Tests / Vascular Endothelial Growth Factor A Type of study: Prognostic study Language: English Journal: Biomolecules & Therapeutics Year: 2015 Type: Article